产量(工程)
可扩展性
流动化学
化学
组合化学
环境科学
工艺工程
计算机科学
有机化学
材料科学
催化作用
工程类
数据库
冶金
作者
Manuel Köckinger,Christopher A. Hone,Bernhard Gutmann,Paul Hanselmann,Michaël Bersier,Ana Torvisco,Christian Oliver Kappe
标识
DOI:10.1021/acs.oprd.8b00318
摘要
The development of a scalable telescoped continuous flow procedure for difluoromethylation of a protected amino acid with fluoroform (CHF 3, R-23) gas and subsequent high temperature deprotection to provide eflornithine, an important Active Pharmaceutical Ingredient (API), is described. Eflornithine is used for the treatment of sleeping sickness and hirsutism, and it is on the World Health Organization’s list of essential medicines. Fluoroform is produced in large quantities as a side product in the manufacture of polytetrafluoroethylene (PTFE, Teflon). Fluoroform is an ozone-benign and nontoxic gas, but its release into the environment is forbidden under the Kyoto protocol owing to its high global warming potential. The existing manufacturing route to eflornithine uses chlorodifluoromethane (CHClF 2, R-22) which will be phased out under the Montreal protocol; therefore, the use of the fluoroform presents a viable cost-effective and more sustainable alternative. The process parameters and equipment setup were optimized on laboratory scale for the two reaction steps to improve product yield and scalability. The telescoped flow process utilizing fluoroform gas was operated for 4 h to afford the target molecule in 86% isolated yield over two steps with a throughput of 24 mmol/h.
科研通智能强力驱动
Strongly Powered by AbleSci AI